Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI
Clearmind Medicine Inc. has announced successful formulation feasibility results for intranasal delivery of its lead therapeutic candidate MEAI, aimed at treating alcohol use disorder (AUD). The study demonstrates that MEAI can be stably formulated for intranasal administration, potentially enhancing therapeutic performance and patient convenience.…